ESG DATA CORE

Client Focus · CIS Pharma

Evidence-grade compliance for pharmaceutical and life-sciences supply chains.

Pharma already lives under audit: GxP, qualified suppliers, validated data. CIS Pharma extends that discipline to sustainability and supply-chain compliance — API sourcing, human rights due diligence and emissions — with the traceability regulators and auditors expect.

Where the risk concentrates

The exposure is specific to your sector.

API and ingredient sourcing

Active ingredients and excipients come from concentrated, opaque supplier networks — a single disruption halts production lines.

Overlapping audit regimes

GxP qualification, CSRD, CSDDD and EU GMP inspections each demand their own evidence — usually collected repeatedly, by hand.

Cold chain and continuity

Temperature-controlled logistics and climate exposure translate directly into product loss and patient risk.

How CIS supports you

Evidence, suppliers and risk — connected for CIS Pharma.

Audit-ready evidence vault

Versioned, approved, traceable documentation — one evidence base reused across GxP, ESG and customer audits.

Supplier qualification workflow

Questionnaires, certifications and due diligence tracked per supplier, with gaps flagged and follow-ups automated.

Continuity risk alerts

Concentration, geography and climate hazards scored per supplier and site — before they become stock-outs.

Compliance discipline pharma already trusts.

Book a call